Business Context and Reporting Period
Company: IRADIMED CORP
Filing Type: Form 8-K (Current Report)
Date of Report: December 22, 2014
Reporting Period: Event date of December 22, 2014
This filing serves as a Regulation FD disclosure regarding the resumption of domestic shipments for the company's MRI compatible MRidium 3860 IV infusion pump systems.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a specific operational event rather than periodic financial results.
Material Changes
- Operational Resumption: IRADIMED announced the resumption of domestic shipments for its MRidium 3860 IV infusion pump systems.
- Product Specifics: The shipment resumption applies specifically to MRI compatible systems.
Guidance, Outlook, and Risks
Management Commentary: The company issued a press release (Exhibit 99.1) confirming the operational update. No forward-looking financial guidance or specific risk factors were detailed within the text of this 8-K filing.
Unusual Items: The filing implies a prior interruption in shipments for the MRidium 3860 system, which has now been resolved.
Investor Verification Checklist
- Verify the full text of the press release attached as Exhibit 99.1 for details on the cause of the previous shipment halt.
- Confirm the timeline for when the shipment interruption began and the volume of units expected to be shipped immediately.
- Assess the impact of the shipment resumption on the company's backlog and near-term revenue recognition.